
Sanegene Biorevenue
Woburn, MassachusettsFounded 2021CEO Weimin Wang
Sanegene Bio is a global biotech company dedicated to developing best-in-class RNA interference (RNAi) therapeutics aimed at addressing obesity, cardiometabolic, and autoimmune diseases.
Sanegene Bio revenue
Sanegene Bio has not published its revenue. Growjo puts it at about $4.3M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $4.3MEST | Growjo estimate |
Sanegene Bio CEO & employees
Weimin Wang is CEO of Sanegene Bio. Sanegene Bio has 22 employees (September 2025, LinkedIn).
- Weimin WangCEO
Sanegene Bio FAQ
What is Sanegene Bio's revenue?
Growjo estimates Sanegene Bio's revenue at about $4.3M a year (September 2025). The company hasn't published its own figure.
How many employees does Sanegene Bio have?
Sanegene Bio has 22 employees as of September 2025, according to LinkedIn.
Who is the CEO of Sanegene Bio?
Weimin Wang is the CEO of Sanegene Bio.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Sanegene Bio? Join the podcast